Galaxy Diagnostics, Inc. Submits SEC Filing: Key Updates Revealed
Galaxy Diagnostics, Inc. recently submitted a filing to the Securities and Exchange Commission (SEC), marked as form D. Form D is a document that companies file with the SEC to notify the agency about the sale of securities without needing to register them for public sale. This filing is significant as it indicates that Galaxy Diagnostics, Inc. is raising capital through the sale of securities.
Galaxy Diagnostics, Inc. is a company focused on providing advanced diagnostic testing for infectious diseases. They offer innovative solutions for the detection of tick-borne illnesses, such as Lyme disease, through their proprietary testing technology. Their commitment to accurate and timely diagnostics has positioned them as a leader in the field of infectious disease testing. For more information about Galaxy Diagnostics, Inc., you can visit their website here.
In conclusion, the submission of form D by Galaxy Diagnostics, Inc. highlights their efforts to raise capital for further development and expansion of their diagnostic testing services. As a company at the forefront of infectious disease diagnostics, Galaxy Diagnostics, Inc. continues to make strides in providing accurate and reliable testing solutions for healthcare providers and patients alike.
Read More:
Galaxy Diagnostics, Inc. Submits SEC Filing as D – Galaxy Diagnostics, Inc. (0001462444) (Filer)
